These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11829462)

  • 1. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal down syndrome brain.
    Gulesserian T; Kim SH; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2002 Feb; 291(1):62-7. PubMed ID: 11829462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain.
    Weitzdoerfer R; Fountoulakis M; Lubec G
    Biochem Biophys Res Commun; 2002 May; 293(2):836-41. PubMed ID: 12054546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).
    Peyrl A; Weitzdoerfer R; Gulesserian T; Fountoulakis M; Lubec G
    Electrophoresis; 2002 Jan; 23(1):152-7. PubMed ID: 11824616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deranged hypothetical proteins Rik protein, Nit protein 2 and mitochondrial inner membrane protein, Mitofilin, in fetal Down syndrome brain.
    Myung J; Gulesserian T; Fountoulakis M; Lubec G
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):739-46. PubMed ID: 14528910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain.
    Bernert G; Fountoulakis M; Lubec G
    Proteomics; 2002 Dec; 2(12):1752-7. PubMed ID: 12469345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifold reduction of moesin in fetal Down syndrome brain.
    Lubec B; Weitzdoerfer R; Fountoulakis M
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1191-4. PubMed ID: 11527426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down syndrome.
    Freidl M; Gulesserian T; Lubec G; Fountoulakis M; Lubec B
    J Neural Transm Suppl; 2001; (61):47-57. PubMed ID: 11771760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derangement of hypothetical proteins in fetal Down's syndrome brain.
    Shin JH; Gulesserian T; Weitzdoerfer R; Fountoulakis M; Lubec G
    Neurochem Res; 2004 Jun; 29(6):1307-16. PubMed ID: 15176487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome.
    Gulesserian T; Engidawork E; Fountoulakis M; Lubec G
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):733-8. PubMed ID: 14528909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain.
    Sun Y; Dierssen M; Toran N; Pollak DD; Chen WQ; Lubec G
    J Proteomics; 2011 Apr; 74(4):547-57. PubMed ID: 21262400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of proteins in fetal brain with Down syndrome.
    Cheon MS; Fountoulakis M; Dierssen M; Ferreres JC; Lubec G
    J Neural Transm Suppl; 2001; (61):311-9. PubMed ID: 11771754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brains.
    Kim SH; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):109-16. PubMed ID: 11771736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex.
    Bajo M; Fruehauf J; Kim SH; Fountoulakis M; Lubec G
    Proteomics; 2002 Nov; 2(11):1539-46. PubMed ID: 12442254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein.
    Canton DA; Olsten ME; Kim K; Doherty-Kirby A; Lajoie G; Cooper JA; Litchfield DW
    Mol Cell Biol; 2005 May; 25(9):3519-34. PubMed ID: 15831458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure.
    Weitzdoerfer R; Dierssen M; Fountoulakis M; Lubec G
    J Neural Transm Suppl; 2001; (61):59-70. PubMed ID: 11771761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of molecular chaperones in brain of patients with Down syndrome.
    Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
    Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotide-binding protein in fetal Down syndrome brain.
    Weitzdoerfer R; Stolzlechner D; Dierssen M; Ferreres J; Fountoulakis M; Lubec G
    J Neural Transm Suppl; 2001; (61):347-59. PubMed ID: 11771757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1.
    Yoo BC; Fountoulakis M; Dierssen M; Lubec G
    J Neural Transm Suppl; 2001; (61):321-34. PubMed ID: 11771755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential localization and sequence analysis of capping protein beta-subunit isoforms of vertebrates.
    Schafer DA; Korshunova YO; Schroer TA; Cooper JA
    J Cell Biol; 1994 Oct; 127(2):453-65. PubMed ID: 7929588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain.
    Weitzdoerfer R; Fountoulakis M; Lubec G
    J Neural Transm Suppl; 2001; (61):95-107. PubMed ID: 11771764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.